Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DuPont de Nemours Inc (DD) vs Procter & Gamble Co (PG) Price & Performance

DuPont de Nemours IncTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs Procter & Gamble Co — how do they compare? DuPont de Nemours Inc trades at $143.83 (market cap $19.12B), while Procter & Gamble Co trades at $144.62 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 17.8× DuPont de Nemours Inc's market cap, and Procter & Gamble Co pays the higher dividend (2.97%). Which is the better fit depends on your goals.

DDPG
Market Cap
$19.12B$340.39B
Sector
Basic MaterialsConsumer Staples
52-Week High
$154.59$167.18
52-Week Low
$87.72$138.10
Enterprise Value
$20.50B$366.23B
Dividend Yield
1.7%2.97%
Volume
6,423,436

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DuPont de Nemours Inc

DuPont (DD) trades at $142.48, down 1.06% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported Q2 2026 earnings that beat expectations, with EPS of $1.88 versus $1.76 expected, and raised its full-year 2026 outlook, driven by healthcare, industrial water, and aerospace demand. However, 2025 fundamentals show a net loss of $779 million on revenue of $6.85 billion, with a high P/E ratio of 61.15 indicating premium valuation.

The outlook is cautiously optimistic, supported by earnings momentum and innovation awards, but risks include ongoing legal settlements over PFAS chemicals and thin net margins. The consensus price target of $232.80 suggests significant upside potential if operational improvements continue.

Procter & Gamble Co

Procter & Gamble (PG) trades at $144.77, down 0.69% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong fundamentals with $84.28B revenue, 18.44% net margin, and consistent dividend payments, though valuation multiples remain elevated versus peers. Recent news highlights institutional positioning shifts and the company's new WNBA partnership.

PG offers stable cash flows and dividend growth potential but faces premium valuation concerns and modest revenue growth outlook. Near-term catalysts include Q3 2026 earnings, while risks include competitive pressures and economic sensitivity. Analyst consensus remains positive with a $161.20 price target suggesting 11% upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG